Actively Recruiting
Sustainable and Inclusive Use of Alternative Proteins in Mediterranean Supply Chains (CIPROMED)
Led by University of Bologna · Updated on 2026-05-04
40
Participants Needed
1
Research Sites
45 weeks
Total Duration
On this page
Sponsors
U
University of Bologna
Lead Sponsor
I
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Collaborating Sponsor
AI-Summary
What this Trial Is About
This study investigates the effects of foods enriched with alternative protein sources, including edible insects, microalgae, hemp, and legumes, on appetite regulation, satiety, food preferences, and metabolic health in healthy adults and individuals with overweight. The study is part of the CIPROMED project, which aims to support sustainable and circular food systems in the Mediterranean area. The study consists of two phases. In the acute phase, participants will consume different protein-enriched bread products in a controlled setting following a randomized crossover design. Each participant will be exposed to multiple test conditions, allowing within-subject comparisons of postprandial responses. Outcomes assessed during this phase include satiety, hunger, food preference, craving, and short-term energy intake, measured using validated scales and dietary assessment tools. In the chronic phase, participants will follow structured dietary interventions over a longer period within a Mediterranean dietary framework. Participants will be assigned to different dietary patterns including alternative protein-based foods and control products. This phase aims to evaluate the effects of repeated consumption of alternative protein sources on metabolic parameters, gastrointestinal tolerance, nutritional status, and behavioral responses. The study aims to assess the acceptability and physiological effects of alternative protein sources and to compare their impact with that of traditional protein sources commonly used in Mediterranean diets.
CONDITIONS
Official Title
Sustainable and Inclusive Use of Alternative Proteins in Mediterranean Supply Chains (CIPROMED)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Providing signed informed consent
- Being between 18 and 65 years of age
- Having a body mass index (BMI) between 18.5 and 24.9 kg/m² (normal range) or between 25.0 and 34.9 kg/m² (overweight or class I obesity)
You will not qualify if you...
- History of allergy to legumes, insects, microalgae, shellfish, mollusks, crustaceans, snails, insect venom, house dust mites, or any ingredients in the test foods
- Confirmed or suspected diagnosis of Celiac Disease
- History of severe allergic reactions to any allergen
- Pregnancy or breastfeeding
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Bologna, Department of Medical and Surgical Sciences
Bologna, BO, Italy, 40138
Actively Recruiting
Research Team
M
Maria Letizia Petroni, Professor
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
BASIC_SCIENCE
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here